Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Venous thrombosis Stories

2014-04-11 23:01:36

The Firm is evaluating Pradaxa lawsuits on behalf of individuals who allegedly suffered dangerous episodes of internal bleeding due to Pradaxa. New York, New York (PRWEB) April 11, 2014 As thousands of Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to move forward in federal court, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) has approved a new indication for the blood thinner. According to an April 7th announcement from Boehringer...

2014-04-08 12:31:49

Three pivotal trials showed PRADAXA as non-inferior to warfarin in reduction of DVT and PE recurrence; fourth pivotal trial showed PRADAXA reduced risk of recurrence by 92 percent compared to placebo RIDGEFIELD, Conn., April 8, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa(®) (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in...

2014-04-07 08:31:34

Three pivotal trials showed PRADAXA as non-inferior to warfarin in reduction of DVT and PE recurrence; fourth pivotal trial showed PRADAXA reduced risk of recurrence by 92 percent compared to placebo RIDGEFIELD, Conn., April 7, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa(®) (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in...

2014-04-01 23:31:09

The DrugNews Center is the web’s most comprehensive source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) April 01, 2014 The birth control safety center DrugNews.net is alerting women who have taken the oral contraceptives Yaz or Yasmin of updated legal news on the site. The most recent court records indicate the number of lawsuits alleging blood clot side effects dropped for the month of March*. DrugNews is a free...

2014-03-25 23:36:20

The DrugNews Center is the web’s most comprehensive source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) March 25, 2014 The birth control safety advocates at DrugNews.net are alerting those women who have taken the oral contraceptives Yaz or Yasmin of the latest Yaz report on the site. Court records for March show the number of lawsuits alleging the drugs caused side effects like blood clots decreasing as the number of...

2014-03-24 20:23:44

The International Society on Thrombosis and Haemostasis partners with thrombosis related organizations from every continent to launch World Thrombosis Day focused on single cause of top 3 cardiovascular deaths worldwide CHAPEL HILL, N.C., March 24, 2014 /PRNewswire-USNewswire/ -- Bringing together nations and local communities to tackle thrombosis, the quiet, underlying disorder that is the common mechanism of the world's three top cardiovascular killers - heart attack, stroke and venous...

2014-03-24 08:27:40

- Subgroup analyses of East Asian populations from two phase 3 studies, ENGAGE AF-TIMI 48 and Hokusai-VTE, showed consistent results compared to the global study populations from these trials(1,2,3,4) TOKYO, March 24, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced late-breaking data from two pre-specified subgroup analyses of East Asian patients with non-valvular atrial fibrillation (NVAF) or venous thromboembolism (VTE) enrolled in two phase...

2014-03-20 23:28:49

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com. New York, NY (PRWEB) March 20, 2014 The birth control safety advocates at DrugRisk.com have added new information to the site for patients who used the contraceptives Yaz or Yasmin. Recent court records show the number of pending lawsuits alleging the drugs caused side effects like blood clots has fallen for March*. DrugRisk was...

2014-03-20 00:21:35

Insufficient medical care of blood clots in the extremities is prevalent, but Dr. Malekmehr of the California Institute for Deep Venous Thrombosis takes an active approach LOS ANGELES, March 19, 2014 /PRNewswire/ -- A blood clot in the lower part of the body, or deep vein thrombosis, is a well-known but often misunderstood syndrome despite its potentially grave consequences. Fortunately, widely respected board certified cardiovascular surgeon Dr. Farshad Malekmehr of the California...

2014-03-18 23:02:37

Merck & Co. Has Agreed to Pay $100 Million to Settle Thousands of NuvaRing Blood Clot Lawsuits Now Pending in State and Federal Courts, But it is Contingent on 95% Approval of Women Plaintiffs. Columbus, OH (PRWEB) March 18, 2014 Wright & Schulte LLC, an experienced medical device injury law firm representing numerous women in NuvaRing lawsuits, reports that the deadline for opting out of the recently announced NuvaRing settlement has been extended until March 25, 2014. According...